Neola Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9.96	16.12	19.56	21.58	40.09	22.94
Cash & Short-Term Investments	9.96	16.12	19.56	21.58	40.09	22.94
Cash Growth	-69.52%	-17.56%	-9.38%	-46.17%	74.76%	37.80%
Other Receivables	-	0.64	0.98	20.85	1.02	1.45
Total Trade Receivables	-	0.64	0.98	20.85	1.02	1.45
Other Current Assets	-	0.48	0.51	0.68	0.49	0.4
Total Current Assets	11.11	17.24	21.04	43.11	41.6	24.79
Net Property, Plant & Equipment	0.2	0.22	0.2	0.14	0.22	0.16
Other Intangible Assets	63.84	122.43	104.74	85.55	67.01	37.76
Long-Term Investments	0.15	0.13	0	-	-	-
Other Long-Term Assets	-	0.13	0	-	-	-
Total Assets	75.3	78.8	73.61	86.02	75.33	43.83
Accounts Payable	-	0.91	1.07	2.18	1.49	1.3
Accrued Expenses	1.72	1.56	2	1.62	1.79	1.44
Other Current Liabilities	1.34	0.53	1.59	2.36	2.06	0.46
Total Current Liabilities	3.07	3	4.65	6.16	5.35	3.19
Other Long-Term Liabilities	-	-	-	0.83	2.5	0
Total Long-Term Liabilities	-	-	-	0.83	2.5	0
Total Liabilities	3.07	3	4.65	6.99	7.85	3.19
Common Stock	-	5.57	5.01	3.98	3.98	1.5
Additional Paid-in Capital	-	116.38	99.08	100.11	79.56	44.83
Accumulated Other Comprehensive Income	-	53.68	45.4	35.45	25.83	16.59
Retained Earnings	-	-99.83	-80.52	-60.52	-41.88	-22.29
Shareholders' Equity	72.23	75.8	68.96	79.03	67.49	40.63
Total Liabilities & Equity	75.3	78.8	73.61	86.02	75.33	43.83
Net Cash (Debt)	9.96	16.12	19.56	21.58	40.09	22.94
Net Cash Growth	-69.52%	-17.56%	-9.38%	-46.17%	74.76%	37.80%
Net Cash Per Share	0.13	0.21	0.28	0.39	1.54	1.64
Book Value	72.23	75.8	68.96	79.03	67.49	40.63
Book Value Per Share	0.93	0.99	0.98	1.42	2.59	2.90
Tangible Book Value	8.39	-46.63	-35.77	-6.52	0.47	2.87
Tangible Book Value Per Share	0.11	-0.61	-0.51	-0.12	0.02	0.21